Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnancy Complications, Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00844428
What this trial is testing

Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 5
Not applicableStudy completedNCT03784794
What this trial is testing

Patient Blood Management for Massive Obstetric Hemorrhage

Who this might be right for
Post Partum HemorrhageFibrinogenolysis; HemorrhageFibrinogen; Deficiency, Acquired+2 more
Angel Augusto Perez Calatayud 100
Testing effectiveness (Phase 2)Looking for participantsNCT06889948
What this trial is testing

The Effect of Daratumumab in Patients With Monoclonal Gammopathy of Renal Significance (MGRS) in Finland

Who this might be right for
Kidney FailureParaproteinemiasGlomerulonephritis
Helsinki University Central Hospital 30
Not applicableLooking for participantsNCT06147414
What this trial is testing

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Who this might be right for
Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, IncludingSickle Cell DiseaseCystic Fibrosis+12 more
Assistance Publique - Hôpitaux de Paris 550
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Early research (Phase 1)Ended earlyNCT04025216
What this trial is testing

CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerOvarian CancerFallopian Tube Cancer+3 more
Kite, A Gilead Company 16
Not applicableLooking for participantsNCT04278404
What this trial is testing

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Who this might be right for
Coronavirus Infection (COVID-19)Pulmonary Arterial HypertensionUrinary Tract Infections in Children+22 more
Duke University 5,000
Early research (Phase 1)Study completedNCT00097747
What this trial is testing

Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure+1 more
Affymax 28
Not applicableLooking for participantsNCT05366881
What this trial is testing

CfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Who this might be right for
Brain CancerBreast CancerBladder Cancer+17 more
Adela, Inc 7,000
Post-approval studies (Phase 4)Study completedNCT00368901
What this trial is testing

STAAR-2 Clinical Study

Who this might be right for
Chronic Kidney DiseaseChronic Renal InsufficiencyKidney Disease+2 more
Amgen 618
Large-scale testing (Phase 3)Study completedNCT04463056
What this trial is testing

Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH

Who this might be right for
Paroxysmal Nocturnal HemoglobinuriaMarchiafava-Micheli SyndromeParoxysmal Hemoglobinuria
AO GENERIUM 32
Testing effectiveness (Phase 2)UnknownNCT02781155
What this trial is testing

Limiting Chemotherapy Side Effects by Using Moxa

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsGenital Neoplasms, Female+1 more
East and North Hertfordshire NHS Trust 25
Not applicableNot Yet RecruitingNCT06792448
What this trial is testing

Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study

Who this might be right for
Nephrotic Syndrome Steroid-DependentNephrotic Syndrome Steroid-ResistantNephrotic Syndrome in Children+5 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 350
Post-approval studies (Phase 4)Study completedNCT00224055
What this trial is testing

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

Who this might be right for
Anemia, Iron-DeficiencyKidney Failure, Chronic
Watson Pharmaceuticals 89
Not applicableStudy completedNCT00563446
What this trial is testing

Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia

Who this might be right for
AnemiaKidney Failure, ChronicPeritoneal Dialysis, Continuous Ambulatory
Hospital Authority, Hong Kong 16
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)Study completedNCT01736397
What this trial is testing

Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis

Who this might be right for
Iron DeficiencyIron Deficiency Anemia
Keryx Biopharmaceuticals 149
Large-scale testing (Phase 3)Looking for participantsNCT05970172
What this trial is testing

Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseRenal Anemia
Astellas Pharma Global Development, Inc. 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04584983
What this trial is testing

Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration

Who this might be right for
Bilirubin Encephalopathy
The University of Texas Health Science Center, Houston 134
Not applicableStudy completedNCT04308603
What this trial is testing

Multicentric Prospective Study to Screen Inborn Errors of Metabolism in Non-immune Hydrops (NIH) Fetalis by Massively Parallel Sequencing

Who this might be right for
Non-Immune Hydrops Fetalis
Hospices Civils de Lyon 71
Next Page